Chers e-mediens,
La "WHO Pharmaceuticals Newsletter" (No. 3, 2008), du 10 oct 2008 est disponible :
Regulatory Matters
Conventional antipsychotics......1
Becaplermin.......................1
Epoetins.......................1
Etanercept...................1
Etoricoxib..................2
Fluoroquinolones.................2
Label changes for use in pregnancy.........2
Moxifloxacin......................2
Norfloxacin.............................3
Pegvisomant-somatostatin analogues..............3
Perflutren injectable suspension................3
Rotavirus gastroenteritis vaccine................4
ADR reporting in Finland........................4
Safety of Medicines
Abacavir and abacavir-containing medications......5
Abacavir and abacavir-containing medications......5
BCG vaccine...................................5
Clozapine...........................................5
Fluorescein........................................6
Fluticasone propionate.........................6
Nitrofurantoin............................6
Pioglitazone.....................................7
Rimonabant........................................7
Risperidone, pipamperone................................7
Salbutamol........................................8
Statins....................................8
Strontium ranelate...................................8
TNF antagonists...................................8
Varencicline..............................................9
Risk evaluation and mitigation studies (REMS)....................9
FDA Sentinel Initiative......................................9
Feature
Review of Oseltamivir Reports in Vigibase is reassuring but vigilance for
hepatic and skin disorders recommended........10
http://www.who.int/medicines/publications/newsletter/en/index.html
Bonne journ�e � tous
Carinne Bruneton